Boundless Bio is in a bind. A phase 1/2 trial has revealed the shortcomings of Boundless’ lead candidate, prompting the company to lay off one-third of its staff and pivot to a combination of two ...
He works in mysterious ways.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results